Dual role of 5-HT3 receptors in a rat model of delayed stress-induced visceral hyperalgesia

Pain

Volumn 130, Issue 1-2, 2007, Pages 56-65

  Bradesi, Sylvie ^a,c   Lao, Lijun ^a,c   McLean, Peter G ^d   Winchester, Wendy J ^d   Lee, Kevin ^d   Hicks, Gareth A ^e   Mayer, Emeran A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

5 HT3 receptors; Hyperalgesia; Stress; Visceral nociception

Indexed keywords

ALOSETRON; CAPSAICIN; DRUG VEHICLE; SEROTONIN 3 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG INHIBITION; HYPERALGESIA; INTESTINE DISTENSION; MALE; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; RAT; SENSORY NERVE; STRESS; VAGUS NERVE; VISCERAL PAIN;

ACUTE DISEASE; ANALGESICS, NON-NARCOTIC; ANIMALS; AVOIDANCE LEARNING; BALLOON DILATATION; CAPSAICIN; CARBOLINES; COLON; ELECTROMYOGRAPHY; GASTROINTESTINAL AGENTS; HYPERALGESIA; IRRITABLE BOWEL SYNDROME; MALE; NOCICEPTORS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN, 5-HT3; RECTUM; STRESS, PSYCHOLOGICAL; VAGOTOMY; VAGUS NERVE; VISCERAL AFFERENTS;

EID: 34249809115     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2006.10.028     Document Type: Article

References (34)

1. Bradesi S., Kokkotou E., Simeonidis S., Patierno S., Ennes H.S., Mittal Y., et al. The role of neurokinin 1 receptors in the maintenance of visceral hyperalgesia induced by repeated stress in rats. Gastroenterology 130 (2006) 1729-1742
2. Bradesi S., Ohning G., McLean P.G., Winchester W.J., and Mayer E.A. Role of spinal 5-HT3 receptors in chronic stress-induced visceral hyperalgesia. Gastroenterology 128 (2005) A-221
3. Camilleri M., Northcutt A.R., Kong S., Dukes G.E., McSorley D., and Mangel A.W. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised placebo-controlled trial. Lancet 355 (2000) 1035-1040
4. Chey W.D., and Cash B.D. Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea. Expert Opin Investig Drugs 14 (2005) 185-193
5. Conte D., Legg E.D., McCourt A.C., Silajdzic E., Nagy G.G., and Maxwell D.J. Transmitter content, origins and connections of axons in the spinal cord that possess the serotonin (5-hydroxytryptamine) 3 receptor. Neuroscience 134 (2005) 165-173
6. Delvaux M., Louvel D., Mamet J.P., Campos-Oriola R., and Frexinos J. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 12 (1998) 849-855
7. Drossman D.A. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130 (2006) 1377-1390
8. Glatzle J., Sternini C., Robin C., Zittel T.T., Wong H., Reeve Jr. J.R., and Raybould H.E. Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology 123 (2002) 217-226
9. Green G.M., Scarth J., and Dickenson A. An excitatory role for 5-HT in spinal inflammatory nociceptive transmission: state-dependent actions via dorsal horn 5-HT(3) receptors in the anaesthetized rat. Pain 89 (2000) 81-88
10. Gschossmann J.M., Mayer E.A., Miller J.C., and Raybould H.E. Subdiaphragmatic vagal afferent innervation in activation of an opioidergic antinociceptive system in response to colorectal distension in rats. Neurogastroenterol Motil 14 (2002) 403-408
11. Hamon M., Gallissot M.C., Menard F., Gozlan H., Bourgoin S., and Verge D. 5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord. Eur J Pharmacol 164 (1989) 315-322
12. Kidd E.J., Laporte A.M., Langlois X., Fattaccini C.M., Doyen C., Lombard M.C., et al. 5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals. Brain Res 612 (1993) 289-298
13. 3 receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat. Gut 46 (2000) 474-480
14. Langlois A., Pascaud X., Junien J.L., Dahl S.G., and Riviere P.J. Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model. Eur J Pharmacol 318 (1996) 141-144
15. Lembo T., Wright R.A., Bagby B., Decker C., Gordon S., Jhingran P., and Carter E. Team Lotronex Investigator. Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 96 (2001) 2662-2670
16. Million M., Taché Y., and Anton P. Susceptibility of Lewis and Fisher rats to stress-induced worsening of TNB-colitis: protective role of brain CRF. Am J Physiol Gastrointest Liver Physiol 276 (1999) G1027-G1036
17. Miura M., Lawson D.C., Clary E.M., Mangel A.W., and Pappas T.N. Central modulation of rectal distension-induced blood pressure changes by alosetron, a 5-HT3 receptor antagonist. Dig Dis Sci 44 (1999) 20-24
18. 3 receptor subtype in the rat brain and spinal cord. J Comp Neurol 402 (1998) 385-401
19. Moss H.E., and Sanger G.J. The effects of granisetron, ICS 205-930 and ondansetron on the visceral pain reflex induced by duodenal distension. Br J Pharmacol 100 (1990) 497-501
20. Ness T.J., and Gebhart G.F. Colorectal distension as a noxious visceral stimulus: physiological and pharmacological characterization of pseudoaffective reflexes in the rat. Brain Res 450 (1988) 153-169
21. Randich A., and Gebhart G.F. Vagal afferent modulation of nociception. Brain Res Brain Res Rev 17 (1992) 77-99
22. Raybould H.E., Glatzle J., Robin C., Meyer J.H., Phan T., Wong H., et al. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol Gastrointest Liver Physiol 284 (2003) G367-G372
23. Raybould H.E., and Taché Y. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am J Physiol 255 (1988) G242-G246
24. Ren K., Zhuo M., Randich A., and Gebhart G.F. Vagal afferent stimulation-produced effects on nociception in capsaicin-treated rats. J Neurophysiol 69 (1993) 1530-1540
25. Riering K., Rewerts C., and Zieglgansberger W. Analgesic effects of 5-HT3 receptor antagonists. Scand J Rheumatol Suppl (2004) 19-23
26. Schwetz I., Bradesi S., McRoberts J.A., Sablad M., Miller J.C., Zhou H., et al. Delayed stress-induced colonic hypersensitivity in male Wistar rats: role of neurokinin-1 and corticotropin-releasing factor-1 receptors. Am J Physiol Gastrointest Liver Physiol 286 (2004) G683-G691
27. Sharma H.S., Cervos-Navarro J., and Dey P.K. Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats. Neurosci Res 10 (1991) 211-221
28. Simpson K., Spencer C.M., and McClellan K.J. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting. Drugs 59 (2000) 1297-1315
29. Suzuki R., Morcuende S., Webber M., Hunt S.P., and Dickenson A.H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat Neurosci 5 (2002) 1319-1326
30. Suzuki R., Rahman W., Hunt S.P., and Dickenson A.H. Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury. Brain Res 1019 (2004) 68-76
31. Suzuki R., Rygh L.J., and Dickenson A.H. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 25 (2004) 613-617
32. Washburn B.S., Jiang J.C., Cummings S.L., Dixon K., and Gietzen D.W. Anorectic responses to dietary amino acid imbalance: effects of vagotomy and tropisetron. Am J Physiol 266 (1994) R1922-R1927
33. Zeitz K.P., Guy N., Malmberg A.B., Dirajlal S., Martin W.J., Sun L., et al. The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 22 (2002) 1010-1019
34. Zerbib F., Bruley des Varannes S., Oriola R.C., McDonald J., Isal J.P., and Galmiche J.P. Alosetron does not affect the visceral perception of gastric distension in healthy subjects. Aliment Pharmacol Ther 8 (1994) 403-407